Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017–2023
Over the period 2017-2023, the HIV-1 TDR appeared generally stable in Italy. However, the increased prevalence of major TDR in 2023 confirms the importance of continuous TDR surveillance in newly diagnosed individuals to inform clinical practice.
Authors
- F Bassani
- A Pupo
- Adrian Shallvari
- Ilaria Vicenti (ORCID: https://orcid.org/0000-0002-4306-2960)
- A Cozzi-Lepri
- Leonardo Duca (ORCID: https://orcid.org/0009-0008-2970-2037)
- Federica Carli
- Alessia Lai (ORCID: https://orcid.org/0000-0002-3174-5721)
- Stefano Rusconi (ORCID: https://orcid.org/0000-0002-0375-9990)
- Antonia Bezenchek
- Francesca Lombardi (ORCID: https://orcid.org/0000-0001-5757-8346)
- William Gennari (ORCID: https://orcid.org/0000-0002-8823-8173)
- Laura Pezzati (ORCID: https://orcid.org/0000-0002-7306-342X)
- Valeria Micheli (ORCID: https://orcid.org/0000-0001-5629-3875)
- Francesco Saladini (ORCID: https://orcid.org/0000-0002-9934-377X)
- O El Khalili (ORCID: https://orcid.org/0000-0003-1345-6800)
- A C Ka'e
- E Gentilini Cacciola
- M M Santoro
Institutions
- University of Siena (IT)
- Università Cattolica del Sacro Cuore (IT)
- University of Insubria (IT)
- University of Rome Tor Vergata (IT)
- University of Modena and Reggio Emilia (IT)
- Luigi Sacco Hospital (IT)
- Centre International De Reference Chantal Biya (CM)
- Informa (Italy) (IT)
- Ospedale di Parma (IT)
- Azienda Ospedaliera Ospedale Civile di Legnano (IT)
- University College London (GB)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1016/j.jgar.2025.11.003
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00